Conmed (CNMD) Non Operating Interest Expenses (2010 - 2026)

Conmed (CNMD) has reported Non Operating Interest Expenses for 17 consecutive years, with $7.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses rose 0.75% year-over-year to $7.9 million; the trailing twelve-month figure through Jun 2026 stood at $29.9 million (down 12.56% YoY), and the FY2025 full-year result was $31.1 million, down 16.65% from the prior year.
• Non Operating Interest Expenses rose to $7.9 million in Q2 2026 per CNMD's latest filing, from $7.1 million in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $112.0 million in Q2 2022 and bottomed at $5.0 million in Q1 2022.
• Historically, Non Operating Interest Expenses has averaged $14.6 million across 5 years, with a median of $8.9 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses jumped 1089.08% in 2022, then plunged 91.07% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $8.5 million in 2022, then grew by 11.34% to $9.5 million in 2023, then declined by 6.81% to $8.9 million in 2024, then decreased by 16.78% to $7.4 million in 2025, then climbed by 6.95% to $7.9 million in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $7.9 million, $7.1 million, and $7.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.